Aquatic Insects and Mycobacterium ulcerans: An Association Relevant to Buruli Ulcer Control? by Silva, Manuel T et al.
PLoS Medicine  |  www.plosmedicine.org 0229
Perspectives
February 2007  |  Volume 4  |  Issue 2  |  e63
M
ycobacterium ulcerans infection, 
which can cause Buruli ulcer, 
is the third most common 
human mycobacteriosis worldwide, 
after tuberculosis and leprosy. Buruli 
ulcer occurs predominantly in 
humid tropical areas of Asia, Latin 
America, and, mainly, Africa, where 
the incidence has been increasing, 
surpassing tuberculosis and leprosy in 
some regions [1].
Buruli ulcer is a devastating, 
necrotizing, “skin-eating” disease of the 
poor, sometimes producing massive, 
disﬁ  guring ulcers, with a huge social 
impact [1,2]. Furthermore, both 
Buruli ulcer and its pathogen have 
high scientiﬁ  c interest, with unique, 
enigmatic, and controversial features 
[1–4]. However, research on Buruli 
ulcer has been limited, although interest 
has grown since 1998, when the World 
Health Organization established the 
Global Buruli Ulcer Initiative, and in 
2004 called for urgent action to control 
the disease and to increase research. 
There is no vaccine against Buruli ulcer 
and treatment remains difﬁ  cult [1,2,5]. 
A detailed description of M. ulcerans 
infection, including its clinical aspects, 
is available at http:⁄⁄www.aﬁ  p.org/
Departments/infectious/bu/.
A new area of research is the 
association between arthropods and M. 
ulcerans. And now a new study in PLoS 
Medicine, by Marsollier and colleagues, 
takes our understanding of this 
association further.
Arthropods and Mycobacteria
There is evidence that M. ulcerans is not 
transmitted person-to-person but is an 
environmental pathogen transmitted 
to humans from its aquatic niches 
[6,7]. However, it is not clear how this 
transmission occurs [6,7].
Arthropods can be vectors of many 
infectious agents. The hypothesis 
that arthropods were involved in the 
transmission of M. leprae to humans was 
originally put forward at the end of the 
19th century [8]. This hypothesis was 
intermittently considered and tested 
until the early 1990s, but it was never 
consistently demonstrated.
The hypothesis that predatory aquatic 
insects, including those in the families 
Naucoridae and Belostomatidae 
(order Hemiptera) (Figure 1), were 
transmitters of M. ulcerans from aquatic 
niches to humans was advanced 
in 1999 [9]. The hypothesis was 
later reinforced by Marsollier and 
colleagues on the basis that [10]: (1) 
the salivary glands of Naucoris cimicoides 
are colonised with M. ulcerans upon 
feeding on grubs containing the 
pathogen; (2) M. ulcerans-infected N. 
cimicoides transmit the pathogen to 
mice upon biting; and (3) N. cimicoides 
in Buruli ulcer–endemic areas can be 
naturally colonised by M. ulcerans; this 
colonisation may occur through feeding 
on aquatic snails and ﬁ  sh, which take 
up M. ulcerans from water, mud, and 
aquatic plants [6,7].
These results have reawakened 
previous interest in the association 
between arthropods and human 
mycobacterioses, and have opened a 
new area in Buruli ulcer research.
Immunity to Vector Antigens 
in Arthropod-Borne Diseases
Examples of arthropod-borne diseases 
are leishmaniasis and Lyme disease, 
transmitted by sand ﬂ  ies and by ticks, 
respectively. These haematophagous 
vectors bite the host’s skin to take 
a blood meal. The bite introduces 
the pathogen along with saliva that 
profoundly alters the skin by molecules 
with antihemostatic activity (which 
enable the vector to take an effective 
meal) and immunosuppressive activity 
(which enhances the infectivity of the 
injected pathogen by counteracting 
the host immune response) [11–14]. 
Pre-exposure of mice to these salivary 
antigens induces protective immunity 
against pathogen transmission by 
neutralizing the immunosuppressive 
activity [11,12,14]. Furthermore, 
salivary molecules can adsorb to the 
pathogen [13,15]), a binding that can 
cause the microorganism to become 
an innocent bystander of the host’s 
antisalivary immunity—again leading 
to protection against pathogen 
transmission [12].
Since efforts to develop vaccines 
targeting antigens of arthropod-
borne pathogens have been largely 
disappointing, targeting arthropod 
salivary components provides a 
potential alternative mechanism to 
block the transmission of arthropod-
borne diseases [11,12,14]. Indeed, 
vaccines have been described that 
protect mice against leishmaniasis by 
targeting sand ﬂ  y salivary proteins [14].
The above results indicate that 
immunity to salivary antigens of vectors 
can be an epidemiological biomarker 
of insect biting and of the consequent 
Aquatic Insects and Mycobacterium ulcerans: 
An Association Relevant to Buruli Ulcer 
Control?
Manuel T. Silva*, Françoise Portaels, Jorge Pedrosa
Funding: The authors received no speciﬁ  c funding 
for this article.
Competing Interests: The authors have declared 
that no competing interests exist.
Citation: Silva MT, Portaels F, Pedrosa J (2007) 
Aquatic insects and Mycobacterium ulcerans: An 
association relevant to Buruli ulcer control? PLoS Med 
4(2): e63. doi:10.1371/journal.pmed.0040063
Copyright: © 2007 Silva et al. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in 
any medium, provided the original author and source 
are credited.
Manuel T. Silva is at the Institute for Molecular 
and Cell Biology (IBMC), University of Porto, 
Porto, Portugal. Françoise Portaels is at the 
Mycobacteriology Unit, Department of Microbiology, 
Institute of Tropical Medicine, Antwerp, Belgium. 
Jorge Pedrosa is at the Life and Health Sciences 
Research Institute (ICVS), School of Health Sciences, 
University of Minho, Braga, Portugal.
*To whom correspondence should be addressed. 
E-mail: mtsilva@ibmc.up.pt
The Perspectives section is for experts to discuss the 
clinical practice or public health implications of a 
published article that is freely available online.PLoS Medicine  |  www.plosmedicine.org 0230
immunoprotection against arthropod-
borne diseases. 
These observations prompted 
Marsollier and colleagues to search 
for immune signatures that could be 
correlates of protection against M. 
ulcerans and to investigate the relevance 
of vector salivary antigen–based vaccine 
strategies for Buruli ulcer.
The New Study
Marsollier and colleagues’ new study 
in PLoS Medicine [16] extends the 
authors’ previous observations [10] 
and shows that repeated biting by M. 
ulcerans-free N. cimicoides renders mice 
more resistant to the infection obtained 
through biting by the insects carrying 
M. ulcerans. The researchers also found 
that subcutaneous immunization 
of mice with salivary extracts of M. 
ulcerans-free N. cimicoides protected 
against infection following injection of 
M. ulcerans, but only when the bacilli 
were ﬁ  rst coated with salivary proteins. 
This suggests that the protection 
conferred to mice by previous N. 
cimicoides biting is associated with 
antibodies (detected in the blood of 
repeatedly bitten mice) reacting with 
proteins of N. cimicoides saliva that 
would bind to M. ulcerans during its 
stay in the insect’s salivary glands, and 
would coat the bacilli when they are 
transmitted by biting.
The new study did not analyse the 
mechanism of this protection, but one 
possibility is that M. ulcerans transmitted 
by N. cimicoides to a sensitised host 
would become the innocent bystander 
target of the immune response against 
the adsorbed salivary proteins, resulting 
in host protection [12]. These results 
suggest that inhabitants of Buruli 
ulcer–endemic areas could become 
naturally immunised if repeatedly 
bitten by uninfected N. cimicoides, a 
mechanism for protection that has 
also been suggested for leishmaniasis 
[12,14,17] and Lyme disease [18]. 
The observation that unaffected, 
possibly resistant people exposed 
to aquatic environments in Buruli 
ulcer–endemic areas have higher titers 
of antibodies reacting with Naucoridae 
and Belostomatidae salivary proteins 
than do patients with Buruli ulcer in 
the same areas [16] is consistent with 
this hypothesis. This observation also 
suggests that biting of humans by 
N. cimicoides and immunity to those 
proteins occur in a natural setting.
Limitations of the New Study
There are three major limitations to 
the new study. The ﬁ  rst is that the study 
did not analyse whether the antibodies 
against insect salivary proteins in mice 
protected by prior biting by uninfected 
N. cimicoides are effectors of protection 
or only biomarkers of the protective 
status. Additional studies are, thus, 
necessary to clarify the roles of humoral 
and cell-mediated immunity in such 
protection.
Second, studies by Marsollier 
and others have been centered on 
Naucoridae, but it is possible that 
Belostomatidae and other predatory 
aquatic insects are also transmitters 
of M. ulcerans [9,16], which could 
complicate the investigation by 
extending the list of relevant insect 
salivary proteins. Another source of 
complication could be the occurrence of 
extensive polymorphisms in the relevant 
salivary proteins; the extent of these 
polymorphisms should be studied using 
specimens of aquatic insects collected in 
different geographical areas.
Third, a general lack of knowledge 
about the transmission of M. ulcerans 
is pertinent to this study—the overall 
relevance and contribution of biting 
by M. ulcerans-colonised aquatic 
insects to the transmission of Buruli 
ulcer is unknown. While sand ﬂ  ies 
and ticks are haematophagous, and 
biting is indispensable both for 
vector survival and for transmission 
of the disease [11], Naucoridae and 
Belostomatidae are carnivorous insects 
and only accidentally bite humans [7]. 
Therefore, other forms of transmission 
of M. ulcerans to humans, including 
skin trauma, have also been considered 
[1,5–7,19].
Implications
If future work supports the notion that 
aquatic insects are important in the 
transmission of the causative organism 
in Buruli ulcer, as some data suggest 
[9,10,16], the results now published 
in PLoS Medicine could have important 
public health implications.
First, following the work with murine 
leishmaniasis [14], attempting to 
develop a Buruli ulcer vaccine that 
targets N. cimicoides salivary antigens 
would be justiﬁ  able. (It must be kept 
in mind, however, that the progress 
with vaccines against arthropod-borne 
diseases based on salivary proteins 
of vectors has been slow. Because 
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Figure 1. Semiaquatic Hemiptera That Have Tested Positive for M. ulcerans
The top two images show Macrocoris sp. 1.0 cm in body length (family Naucoridae), and the 
bottom two images show Appasus sp., about 2.5 cm in body length (family Belostomatidae). The 
ventral and dorsal views are in the left and right photographs, respectively. Photo from [2].PLoS Medicine  |  www.plosmedicine.org 0231
of scientiﬁ  c, technical, and safety 
problems [12,14], such vaccines still 
remain unavailable for human use.) In 
addition, the presence of antibodies 
against salivary antigens of aquatic 
insects may be an important biomarker 
of protective status against Buruli ulcer, 
with epidemiological relevance in the 
study of populations at risk in endemic 
areas of the disease.  
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